Repro Med Systems Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.6% | +14.1% | +2.8% | -3.0% | +8.1% | +9.0% | +5.8% | +2.0% | +4.7% | +8.0% | +2.4% | – | |
| – | +7.3% | +8.4% | -4.7% | +1.5% | +9.4% | +9.6% | +3.6% | +11.3% | -1.4% | +16.0% | -11.2% | – | |
| – | -0.3% | +17.8% | +7.4% | -5.4% | +7.3% | +8.7% | +7.1% | -3.3% | +8.8% | +3.2% | +11.5% | – | |
| – | -0.4% | +14.6% | -23.1% | +35.2% | -27.4% | +0.0% | +7.2% | -21.9% | +22.7% | +15.0% | -18.8% | – | |
| – | +8.4% | +6.9% | -0.7% | -3.6% | +13.6% | +2.3% | -9.7% | +11.3% | +0.8% | +9.0% | -9.8% | – | |
| – | +6.4% | +8.2% | -5.6% | +3.3% | +3.8% | +1.9% | -6.9% | +5.1% | +3.3% | +7.3% | -8.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -96.5% | -100.0% | – | – | – | – | -100.9% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -2,971.6% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.